Shots: Nanobiotix to receive a $20M up front and is eligible to receive ~$220 M as contingent payments and milestones along with royalties on net sales of NBTXR3 in the […]readmore
Tags : Singapore
Shots: SlngXpand will conduct clinical studies of expanded in vitro expanded peripheral blood CD34+ stem cells, CellProThera will fund the clinical studies and to receive exclusive commercialization rights of […]readmore